跳至主要内容
临床试验/CTRI/2023/03/050874
CTRI/2023/03/050874招募中2 期

A Single Arm Clinical Study to evaluate the efficacy of Navneet Gudadi Lepa in the management of Vyanga(Melasma)

Dr. Gangarapu Kiranmai1 个研究点 分布在 1 个国家目标入组 34 人开始时间: 2023年1月4日最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
34
试验地点
1
主要终点
Relieve in symptoms like darkness and area reduction in the affected area of skin

研究概览

简要总结

It is A Clinical study to evaluate the effect of Navneet Gudadi lepa in the management of Vyangh  (Melasma)

Study design is Single arm clinical study

Total 34 patients will be enrolled

Assessment of patients on 1st and 7th day

Total duration of study will be 18 months.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients of age between 18-60 years irrespective of their sex, occupation and religion.
  • Having symptoms of vyanga like niruja(painless), tanu(thin), shyava varna(blackish patch).

排除标准

  • Known case of any skin malignancy.
  • Any skin allergy.

结局指标

主要结局

Relieve in symptoms like darkness and area reduction in the affected area of skin

时间窗: 7 days.

次要结局

  • To assess the improvemant of homogenity and darkness of affected skin.(7 days)

研究者

发起方
Dr. Gangarapu Kiranmai
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验